Log Type Authored on Log Message Log Node Authored by
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/should-antipsychotic-medications-be-stopped-early-possible-after-first-episode-1 Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/can-gender-specific-screening-tools-aid-recognition-male-depression-3 Анонимен
Newsletter clicked Clicked https://progress.im/en/newsletter/confirm/remove Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/personalizing-antipsychotic-therapy-improve-functional-outcomes-and-quality-life-4 Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/if-first-you-don%E2%80%99t-succeed-try-another-cgrp-antibody-migraine-prevention-1 Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
User created User created Анонимен
Newsletter opened Opened Depressão resistente: otimizando o tratamento precoce para redução do impacto da doença Анонимен
OWA Status Updating trust level from 1 to 2 Анонимен
Newsletter opened Opened Анонимен
Newsletter subscribed Newsletter subscribed - Boletín informativo de Progress in Mind LATAM Анонимен
User created User created Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Log Type Authored on Log Message Log Node Authored by
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/should-antipsychotic-medications-be-stopped-early-possible-after-first-episode-1 Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/can-gender-specific-screening-tools-aid-recognition-male-depression-3 Анонимен
Newsletter clicked Clicked https://progress.im/en/newsletter/confirm/remove Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/personalizing-antipsychotic-therapy-improve-functional-outcomes-and-quality-life-4 Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/if-first-you-don%E2%80%99t-succeed-try-another-cgrp-antibody-migraine-prevention-1 Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
User created User created Анонимен
Newsletter opened Opened Depressão resistente: otimizando o tratamento precoce para redução do impacto da doença Анонимен
OWA Status Updating trust level from 1 to 2 Анонимен
Newsletter opened Opened Анонимен
Newsletter subscribed Newsletter subscribed - Boletín informativo de Progress in Mind LATAM Анонимен
User created User created Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен